Nexgel (NXGLW) Total Non-Current Liabilities (2018 - 2024)
Nexgel's (NXGLW) quarterly Total Non-Current Liabilities came in at $4.7 million in Q4 2024, up 8.62% YoY from $4.4 million in Q1 2024, and down 11.1% on a QoQ basis from $5.3 million in Q3 2024.
Nexgel (NXGLW) Total Non-Current Liabilities (2018 - 2024) Analysis & Trends
Nexgel (NXGLW) has 7 years of Total Non-Current Liabilities data on file, last reported at $4.7 million in Q4 2024.
- Quarterly Total Non-Current Liabilities rose 8.62% year-over-year to $4.7 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $4.7 million (up 8.62% YoY) and the FY2024 annual result came in at $4.7 million, up 8.62% from the prior year.
- Total Non-Current Liabilities eased to $4.7 million in Q4 2024, from $5.3 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $5.3 million in Q3 2024 to a low of $824000.0 in Q1 2021.
- A 5-year average of $2.9 million and a median of $2.0 million in 2021 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2020 — Total Non-Current Liabilities sank 43.44% — and 2022, when it soared 139.32%.
- Tracing NXGLW's Total Non-Current Liabilities over 5 years: stood at $854000.0 in 2020, then jumped by 135.36% to $2.0 million in 2021, then declined by 5.42% to $1.9 million in 2022, then soared by 128.83% to $4.4 million in 2023, then grew by 8.62% to $4.7 million in 2024.
- The last three Total Non-Current Liabilities figures came in at $4.7 million (Q4 2024), $5.3 million (Q3 2024), and $4.9 million (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 48.34 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 6.34 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 985.45 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 17.56 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 8.96 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 3.98 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 12.41 Bn |
| 10 | Nexgel | 194,000.44 | -994,999.56 | 1.11 Mn | 20.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 4.73 Mn |
| Sep 30, 2024 | 5.32 Mn |
| Jun 30, 2024 | 4.88 Mn |
| Mar 31, 2024 | 4.74 Mn |
| Dec 31, 2023 | 4.35 Mn |
| Sep 30, 2022 | 1.90 Mn |
| Jun 30, 2022 | 1.93 Mn |
| Mar 31, 2022 | 1.97 Mn |
| Dec 31, 2021 | 2.01 Mn |
| Sep 30, 2021 | 2.05 Mn |
| Jun 30, 2021 | 2.07 Mn |
| Mar 31, 2021 | 824,000.00 |
| Dec 31, 2020 | 854,000.00 |
| Dec 31, 2019 | 1.51 Mn |
| Sep 30, 2019 | 1.44 Mn |
| Dec 31, 2018 | 407,000.00 |